Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Human umbilical cord mesenchymal stem cell-derived exosomal miR-455-3p targets CAMK2N1 to improve trophoblast cell injury in gestational diabetes mellitus

Fig. 5

miR-455-3p derived from hucMSCs-Exos targets CAMK2N1 to ameliorate trophoblast cell injury in GDM. A RT-qPCR detection of miR-455-3p expression levels in cells of each group; B, C RT-qPCR and WB detection of CAMK2N1 mRNA and protein expression levels in cells of each group; D CCK-8 detection of cell proliferation in each group; E Transwell detection of cell migration in each group; F. Flow cytometry detection of cell apoptosis in each group; ANOVA was used for comparisons between multiple groups, with post-hoc testing using Tukey’s method, and * indicating P < 0.05. All experiments were repeated more than three times

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us